{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T10:15:32Z","timestamp":1770372932749,"version":"3.49.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03282-6","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T15:36:33Z","timestamp":1763480193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HSPiP and Neuro-Fuzzy Model-Enabled Optimized Nanoemulsions for Nose-to-Brain Delivery of Valproic Acid"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6275-5375","authenticated-orcid":false,"given":"Afzal","family":"Hussain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5686-4964","authenticated-orcid":false,"given":"Osamah A.","family":"Alnemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4877-864X","authenticated-orcid":false,"given":"Mohammad A.","family":"Altamimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"3282_CR1","unstructured":"World Health Organization Epilepsy. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/epilepsy. Accessed on 20th October 2024."},{"key":"3282_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2023.109180","volume":"142","author":"R Kobau","year":"2023","unstructured":"Kobau R, Luncheon C, Greenlund K. Active epilepsy prevalence among U.S. adults is 1.1% and differs by educational level-National health interview survey, United States, 2021. Epilepsy Behav. 2023;142:109180. https:\/\/doi.org\/10.1016\/j.yebeh.2023.109180.","journal-title":"Epilepsy Behav"},{"issue":"2","key":"3282_CR3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000522442","volume":"57","author":"A Al Rumayyan","year":"2023","unstructured":"Al Rumayyan A, Alharthi A, Al-Rowaili M, Al-Mehmadi S, Altwaijri W, Alrifai T, et al. The prevalence of active epilepsy in the Kingdom of Saudi Arabia: a cross-sectional study. Neuroepidemiology. 2023;57(2):78\u201389.","journal-title":"Neuroepidemiology"},{"issue":"45","key":"3282_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000040488","volume":"103","author":"T Boonlue","year":"2024","unstructured":"Boonlue T, Sitsuer P, Phosri W, Jinatongthai W. Factors associated with subtherapeutic levels of valproic acid in hospitalized patients with epilepsy: a retrospective cohort study. Medicine (Baltimore). 2024;103(45):e40488. https:\/\/doi.org\/10.1097\/MD.0000000000040488.","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"3282_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/gels9080603","volume":"9","author":"A Hussain","year":"2023","unstructured":"Hussain A, Altamimi MA, Ramzan M, Mirza MA, Khuroo T. Gastroplus- and hspip-oriented predictive parameters as the basis of Valproic acid-loaded mucoadhesive cationic nanoemulsion gel for improved nose-to-brain delivery to control convulsion in humans. Gels. 2023;9(8):603. https:\/\/doi.org\/10.3390\/gels9080603.","journal-title":"Gels"},{"issue":"1","key":"3282_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0006-8993(82)90664-3","volume":"240","author":"EJ Hammond","year":"1982","unstructured":"Hammond EJ, Perchalski RJ, Villarreal HJ, Wilder BJ. In vivo uptake of valproic acid into brain. Brain Res. 1982;240(1):195\u20138.","journal-title":"Brain Res"},{"issue":"4","key":"3282_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16040481","volume":"16","author":"S Gandhi","year":"2024","unstructured":"Gandhi S, Shastri DH, Shah J, Nair AB, Jacob S. Nasal delivery to the brain: harnessing nanoparticles for effective drug transport. Pharmaceutics. 2024;16(4):481. https:\/\/doi.org\/10.3390\/pharmaceutics16040481.","journal-title":"Pharmaceutics"},{"key":"3282_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124631","volume":"664","author":"AC Correia","year":"2024","unstructured":"Correia AC, Costa I, Silva R, Sampaio P, Moreira JN, Sousa Lobo JM, et al. Design of experiment (DoE) of mucoadhesive valproic acid-loaded nanostructured lipid carriers (NLC) for potential nose-to-brain application. Int J Pharm. 2024;664:124631. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124631.","journal-title":"Int J Pharm"},{"key":"3282_CR9","first-page":"363","volume":"6","author":"S Eskandari","year":"2011","unstructured":"Eskandari S, Varshosaz J, Minaiyan M, Tabbakhian M. Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model. Int J Nanomedicine. 2011;6:363\u201371.","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"3282_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e09030","volume":"8","author":"M Jufri","year":"2022","unstructured":"Jufri M, Yuwanda A, Surini S, Harahap Y. Study of valproic acid liposomes for delivery into the brain through an intranasal route. Heliyon. 2022;8(3):e09030. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09030.","journal-title":"Heliyon"},{"key":"3282_CR11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ultsonch.2015.09.015","volume":"29","author":"SF Tan","year":"2016","unstructured":"Tan SF, Masoumi HRF, Karjiban RA, Stanslas J, Kirby BP, Basri M, et al. Ultrasonic emulsification of parenteral valproic acid-loaded nanoemulsion with response surface methodology and evaluation of its stability. Ultrason Sonochem. 2016;29:299\u2013308.","journal-title":"Ultrason Sonochem"},{"key":"3282_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0099-5428(05)32008-9","volume":"32","author":"IA Alsarra","year":"2005","unstructured":"Alsarra IA, Al-Omar M, Belal F. Valproic acid and sodium valproate: comprehensive profile. Profiles Drug Subst Excip Relat Methodol. 2005;32:209\u201340.","journal-title":"Profiles Drug Subst Excip Relat Methodol"},{"issue":"5","key":"3282_CR13","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1365-2273.1995.tb00077.x","volume":"20","author":"MW Saunders","year":"1995","unstructured":"Saunders MW, Jones NS, Kabala J, Lowe J. An anatomical, histological and magnetic resonance imaging study of the nasal septum. Clin Otolaryngol Allied Sci. 1995;20(5):434\u20138.","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"3282_CR14","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s12555-024-0506-z","volume":"23","author":"MQ Zaman","year":"2025","unstructured":"Zaman MQ, Wu HM. Genetic algorithm based takagi-sugeno fuzzy modelling of a mecanum wheeled mobile robot. Int J Control Autom Syst. 2025;23:907\u201319.","journal-title":"Int J Control Autom Syst."},{"issue":"1","key":"3282_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s13346-018-00592-0","volume":"9","author":"S Rebouh","year":"2019","unstructured":"Rebouh S, Lefnaoui S, Bouhedda M, Yahoum MM, Hanini S. Neuro-fuzzy modeling of ibuprofen-sustained release from tablets based on different cellulose derivatives. Drug Deliv Transl Res. 2019;9(1):162\u201377.","journal-title":"Drug Deliv Transl Res"},{"issue":"14","key":"3282_CR16","doi-asserted-by":"publisher","first-page":"6515","DOI":"10.1080\/19443994.2015.1009171","volume":"57","author":"S Rebouh","year":"2016","unstructured":"Rebouh S, Bouhedda M, Hanini S. Neuro-fuzzy modeling of Cu(II) and Cr(VI) adsorption from aqueous solution by wheat straw. Desalin Water Treat. 2016;57(14):6515\u201330.","journal-title":"Desalin Water Treat"},{"key":"3282_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/15298668891379783","volume":"49","author":"CM Hansen","year":"1988","unstructured":"Hansen CM, Andersen B. The affinities of organic solvents in biological systems. Am Ind Hyg Assoc J. 1988;49:301\u20138.","journal-title":"Am Ind Hyg Assoc J"},{"issue":"2","key":"3282_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0168-3659(97)01635-0","volume":"47","author":"P Schultz","year":"1997","unstructured":"Schultz P, Tho I, Kleinebudde P. A new multiparticulate delayed release system. Part II: Coating formulation and properties of free films. J Control Release. 1997;47(2):191\u20139.","journal-title":"J Control Release"},{"issue":"1","key":"3282_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0165-0114(99)00141-4","volume":"121","author":"J Yoneyama","year":"2001","unstructured":"Yoneyama J, Nishikawa M, Katayama H, Ichikawa A. Design of output feedback controllers for Takagi-Sugeno fuzzy systems. Fuzzy Sets Syst. 2001;121(1):127\u201348.","journal-title":"Fuzzy Sets Syst"},{"key":"3282_CR20","doi-asserted-by":"crossref","unstructured":"Mashreghi N, Bayrami Z. 1-Methyl-2-pyrrolidinone. Encyclopedia of Toxicology (4th Edition) 2024;6: 351\u2013357.","DOI":"10.1016\/B978-0-12-824315-2.00296-7"},{"issue":"3","key":"3282_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jconrel.2006.08.015","volume":"115","author":"T Yang","year":"2006","unstructured":"Yang T, Hussain A, Bai S, Khalil IA, Harashima H, Ahsan F. Positively charged polyethylenimines enhance nasal absorption of the negatively charged drug, low molecular weight heparin. J Control Release. 2006;115(3):289\u201397.","journal-title":"J Control Release"},{"key":"3282_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/gels9060491","volume":"9","author":"KK Abla","year":"2023","unstructured":"Abla KK, Domiati S, El Majzoub R, Mehanna MM. Propranolol-loaded limonene-based microemulsion thermo-responsive mucoadhesive nasal nanogel: design, in vitro assessment, ex vivo permeation, and brain biodistribution. Gels. 2023;9:491. https:\/\/doi.org\/10.3390\/gels9060491.","journal-title":"Gels"},{"issue":"5","key":"3282_CR23","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s13346-019-00634-1","volume":"9","author":"C Leichner","year":"2019","unstructured":"Leichner C, Baus RA, Jelkmann M, Plautz M, Barthelmes J, D\u00fcnnhaupt S, et al. In vitro evaluation of a self-emulsifying drug delivery system (SEDDS) for nasal administration of dimenhydrinate. Drug Deliv Transl Res. 2019;9(5):945\u201355.","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"3282_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1046\/j.1365-2273.1999.00223.x","volume":"24","author":"RJ England","year":"1999","unstructured":"England RJ, Homer JJ, Knight LC, Ell SR. Nasal pH measurement: a reliable and repeatable parameter. Clin Otolaryngol Allied Sci. 1999;24(1):67\u20138.","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"3282_CR25","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.2147\/DDDT.S407475","volume":"17","author":"DA Gaber","year":"2023","unstructured":"Gaber DA, Alsubaiyel AM, Alabdulrahim AK, Alharbi HZ, Aldubaikhy RM, Alharbi RS, et al. Nano-emulsion based gel for topical delivery of an anti-inflammatory drug: In vitro and in vivo evaluation. Drug Des Devel Ther. 2023;17:1435\u201351.","journal-title":"Drug Des Devel Ther"},{"issue":"4","key":"3282_CR26","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.eurpolymj.2009.12.008","volume":"46","author":"CM Hansen","year":"2010","unstructured":"Hansen CM. The significance of the surface condition in solutions to the diffusion equation: explaining \u201canomalous\u201d sigmoidal, Case II, and Super Case II absorption behavior. Eur Polym J. 2010;46(4):651\u201362.","journal-title":"Eur Polym J"},{"issue":"1","key":"3282_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1753-5174.2010.00033.x","volume":"4","author":"JM Christensen","year":"2011","unstructured":"Christensen JM, Chuong MC, Le H, Pham L, Bendas E. Hydrocortisone diffusion through synthetic membrane, mouse skin, and Epiderm\u2122 cultured skin. Arch Drug Inf. 2011;4(1):10\u201321.","journal-title":"Arch Drug Inf"},{"key":"3282_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e09030","volume":"8","author":"A Yuwanda","year":"2022","unstructured":"Yuwanda A, Surini S, Harahap Y, Jufri M. Study of valproic acid liposomes for delivery into the brain through an intranasal route. Heliyon. 2022;8:e09030.","journal-title":"Heliyon"},{"issue":"5","key":"3282_CR29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jpha.2016.05.003","volume":"6","author":"T Masiuk","year":"2016","unstructured":"Masiuk T, Kadakia P, Wang Z. Development of a physiologically relevant dripping analytical method using simulated nasal mucus for nasal spray formulation analysis. J Pharm Anal. 2016;6(5):283\u201391.","journal-title":"J Pharm Anal"},{"key":"3282_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.colsurfb.2014.06.037","volume":"122","author":"TB Devkar","year":"2014","unstructured":"Devkar TB, Tekade AR, Khandelwal KR. Surface engineered nanostructured lipid carriers for efficient nose to brain delivery of ondansetron HCl using Delonix regia gum as a natural mucoadhesive polymer. Colloids Surf B Biointerfaces. 2014;122:143\u201350.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3282_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124631","volume":"664","author":"AC Correia","year":"2024","unstructured":"Correia AC, Costa I, Silva R, Sampaio P, Moreira JN, Lobo JMS, et al. Design of experiment (DoE) of mucoadhesive valproic acid-loaded nanostructured lipid carriers (NLC) for potential nose-to-brain application. Int J Pharm. 2024;664:124631. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124631.","journal-title":"Int J Pharm"},{"issue":"2","key":"3282_CR32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.apsb.2014.02.002","volume":"4","author":"R Pathak","year":"2014","unstructured":"Pathak R, Prasad Dash R, Misra M, Nivsarkar M. Role of mucoadhesive polymers in enhancing delivery of nimodipine microemulsion to brain via intranasal route. Acta Pharm Sin B. 2014;4(2):151\u201360.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"3282_CR33","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.addr.2012.04.011","volume":"65","author":"S Hansen","year":"2013","unstructured":"Hansen S, Lehr C-M, Schaefer UF. Improved input parameters for diffusion models of skin absorption. Adv Drug Deliv Rev. 2013;65(2):251\u201364.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"3282_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5530\/ijper.47.3.6","volume":"47","author":"P Shilpa","year":"2013","unstructured":"Shilpa P, Vibhavari C, Chatur M. Development of valproic acid niosomal in situ nasal gel formulation for epilepsy. Indian J Pharm Educ Res. 2013;47(3):31\u201341.","journal-title":"Indian J Pharm Educ Res"},{"key":"3282_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejpb.2016.02.009","volume":"102","author":"B Hossin","year":"2016","unstructured":"Hossin B, Rizi K, Murdan S. Application of Hansen solubility parameters to predict drug\u2013nail interactions, which can assist the design of nail medicines. Eur J Pharm Biopharm. 2016;102:32\u201340.","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"3282_CR36","first-page":"572","volume":"19","author":"N Ezati","year":"2020","unstructured":"Ezati N, Roberts MS, Zhang Q, Moghimi HR. Measurement of Hansen solubility parameters of human stratum corneum. Iran J Pharm Res. 2020;19(3):572\u20138.","journal-title":"Iran J Pharm Res"},{"key":"3282_CR37","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jcis.2020.04.070","volume":"575","author":"DP Faasen","year":"2020","unstructured":"Faasen DP, Jarray A, Zandvliet HJW, Kooij ES, Kwiecinski W. Hansen solubility parameters obtained via molecular dynamics simulations as a route to predict siloxane surfactant adsorption. J Colloid Interface Sci. 2020;575:326\u201336.","journal-title":"J Colloid Interface Sci"},{"issue":"1","key":"3282_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0040-6031(98)00275-5","volume":"315","author":"JM Davies","year":"1998","unstructured":"Davies JM, Viney C. Water\u2013mucin phases: conditions for mucus liquid crystallinity. Thermochim Acta. 1998;315(1):39\u201349.","journal-title":"Thermochim Acta"},{"issue":"12","key":"3282_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12121230","volume":"12","author":"S Bahadur","year":"2020","unstructured":"Bahadur S, Pardhi DM, Rautio J, Rosenholm JM, Pathak K. Intranasal nanoemulsions for direct nose-to-brain delivery of actives for CNS disorders. Pharmaceutics. 2020;12(12):1230. https:\/\/doi.org\/10.3390\/pharmaceutics12121230.","journal-title":"Pharmaceutics"},{"key":"3282_CR40","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1124\/jpet.119.258152","volume":"370","author":"Z Wang","year":"2019","unstructured":"Wang Z, Xiong G, Tsang WC, Sch\u00e4tzlein AG, Uchegbu IF. Nose-to-brain delivery. J Pharmacol Exp Ther. 2019;370:593\u2013601.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"3282_CR41","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1159\/000320407","volume":"28","author":"W Stremmel","year":"2010","unstructured":"Stremmel W, Hanemann A, Ehehalt R, Karner M, Braun A. Phosphatidylcholine (lecithin) and the mucus layer: evidence of therapeutic efficacy in ulcerative colitis? Dig Dis. 2010;28(3):490\u20136.","journal-title":"Dig Dis"},{"key":"3282_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/colloids7010023","volume":"7","author":"SK Misra","year":"2023","unstructured":"Misra SK, Pathak K. Nose-to-brain targeting via nanoemulsion: significance and evidence. Colloids Interfaces. 2023;7:23. https:\/\/doi.org\/10.3390\/colloids7010023.","journal-title":"Colloids Interfaces"},{"key":"3282_CR43","doi-asserted-by":"publisher","first-page":"156","DOI":"10.2174\/1872211310666160321123936","volume":"10","author":"K Phukan","year":"2016","unstructured":"Phukan K, Nandy M, Sharma RB, Sharma HK. Nanosized drug delivery systems for direct nose to brain targeting: a review. Recent Pat Drug Deliv Formul. 2016;10:156\u201364.","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"3282_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108832","volume":"201","author":"CT Uppuluri","year":"2021","unstructured":"Uppuluri CT, Ravi PR, Dalvi AV. Design and evaluation of thermo-responsive nasal in situ gelling system dispersed with piribedil loaded lecithin-chitosan hybrid nanoparticles for improved brain availability. Neuropharmacology. 2021;201:108832.","journal-title":"Neuropharmacology"},{"issue":"11","key":"3282_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ph13110399","volume":"13","author":"M Suhail","year":"2020","unstructured":"Suhail M, Wu PC, Minhas MU. Using carbomer-based hydrogels for control the release rate of diclofenac sodium: preparation and in vitro evaluation. Pharmaceuticals (Basel). 2020;13(11):399. https:\/\/doi.org\/10.3390\/ph13110399.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"38","key":"3282_CR46","doi-asserted-by":"publisher","first-page":"12155","DOI":"10.1021\/ie301818f","volume":"51","author":"H Jia","year":"2012","unstructured":"Jia H, Zhao J-Z, Jin F-Y, Pu W-F, Li Y-M, Li K-X, et al. New insights into the gelation behavior of polyethyleneimine cross-linking partially hydrolyzed polyacrylamide gels. Ind Eng Chem Res. 2012;51(38):12155\u201366.","journal-title":"Ind Eng Chem Res"},{"key":"3282_CR47","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1016\/j.bmc.2017.11.001","volume":"26","author":"E Samaridou","year":"2018","unstructured":"Samaridou E, Alonso MJ. Nose-to-brain peptide delivery \u2013 the potential of nanotechnology. Bioorg Med Chem. 2018;26:2888\u2013905.","journal-title":"Bioorg Med Chem"},{"key":"3282_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01956","volume":"8","author":"J Chaillot","year":"2017","unstructured":"Chaillot J, Tebbji F, Garc\u00eda C, Wurtele H, Pelletier R, Sellam A. pH-dependant antifungal activity of valproic acid against the human fungal pathogen Candida albicans. Front Microbiol. 2017;8:1956. https:\/\/doi.org\/10.3389\/fmicb.2017.01956.","journal-title":"Front Microbiol"},{"issue":"3","key":"3282_CR49","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1021\/bm010049c","volume":"2","author":"R Rodr\u00edguez","year":"2001","unstructured":"Rodr\u00edguez R, Alvarez-Lorenzo C, Concheiro A. Rheological evaluation of the interactions between cationic celluloses and Carbopol 974P in water. Biomacromolecules. 2001;2(3):886\u201393.","journal-title":"Biomacromolecules"},{"issue":"1\u20132","key":"3282_CR50","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ejps.2012.10.029","volume":"48","author":"S Pund","year":"2013","unstructured":"Pund S, Rasve G, Borade G. Ex vivo permeation characteristics of venlafaxine through sheep nasal mucosa. Eur J Pharm Sci. 2013;48(1\u20132):195\u2013201.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"3282_CR51","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2165\/00003088-198005010-00002","volume":"5","author":"R Gugler","year":"1980","unstructured":"Gugler R, von Unruh GE. Clinical pharmacokinetics of valproic acid. Clin Pharmacokinet. 1980;5(1):67\u201383.","journal-title":"Clin Pharmacokinet"},{"key":"3282_CR52","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/mp800051m","volume":"5","author":"F Alexis","year":"2008","unstructured":"Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm. 2008;5:505\u201315.","journal-title":"Mol Pharm"},{"key":"3282_CR53","first-page":"37","volume":"127","author":"I Andersen","year":"1983","unstructured":"Andersen I, Proctor DF. Measurement of nasal mucociliary clearance. Eur J Respir Dis Suppl. 1983;127:37\u201340.","journal-title":"Eur J Respir Dis Suppl"},{"issue":"2","key":"3282_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11020084","volume":"11","author":"MC Bonferoni","year":"2019","unstructured":"Bonferoni MC, Rossi S, Sandri G, Ferrari F, Gavini E, Rassu G, et al. Nanoemulsions for \u201cnose-to-brain\u201d drug delivery. Pharmaceutics. 2019;11(2):84. https:\/\/doi.org\/10.3390\/pharmaceutics11020084.","journal-title":"Pharmaceutics"},{"key":"3282_CR55","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1111\/jphp.12800","volume":"69","author":"TBP Kirby","year":"2017","unstructured":"Kirby TBP, Stanslas J, Basri HB. Characterization, in-vitro and in-vivo evaluation of valproic acid-loaded nanoemulsion for improved brain bioavailability. J Pharm Pharmacol. 2017;69:1447\u201357.","journal-title":"J Pharm Pharmacol"},{"key":"3282_CR56","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1385\/JMN:16:2-3:181","volume":"16","author":"J Edmond","year":"2001","unstructured":"Edmond J. Essential polyunsaturated fatty acids and the barrier to the brain: the components of a model for transport. J Mol Neurosci. 2001;16:181\u201394.","journal-title":"J Mol Neurosci"},{"key":"3282_CR57","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-1-4614-7978-9_5","volume":"6","author":"JD Ehrick","year":"2013","unstructured":"Ehrick JD, Shah SA, Shaw C, Kulkarni VS, Coowanitwong I, De S, et al. Considerations for the development of nasal dosage forms. AAPS Adv Pharma Sci Ser. 2013;6:99\u2013144.","journal-title":"AAPS Adv Pharma Sci Ser"},{"key":"3282_CR58","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0169-409X(97)00067-7","volume":"29","author":"MT Vidgren","year":"1998","unstructured":"Vidgren MT, Kublik H. Nasal delivery systems and their effect on deposition and absorption. Adv Drug Deliv Rev. 1998;29:157\u201377.","journal-title":"Adv Drug Deliv Rev"},{"key":"3282_CR59","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s13346-018-0580-y","volume":"9","author":"M Gao","year":"2019","unstructured":"Gao M, Mei D, Huo Y, Mao S. Effect of polysorbate 80 on the intranasal absorption and brain distribution of tetramethylpyrazine phosphate in rats. Drug Deliv Transl Res. 2019;9:311\u20138.","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"3282_CR60","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s40005-022-00589-5","volume":"53","author":"SH Jeong","year":"2023","unstructured":"Jeong SH, Jang JH, Lee YB. Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors. J Pharm Investig. 2023;53(1):119\u201352.","journal-title":"J Pharm Investig"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03282-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03282-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03282-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T19:02:17Z","timestamp":1770318137000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03282-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["3282"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03282-6","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent Statement"}},{"value":"The authors report no conflict of interest. All authors have reviewed, revised, and agreed for the publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"36"}}